Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. PT Famon Awal Bros Sedaya Tbk's Marketable Securities for the quarter that ended in Mar. 2026 was Rp45,000 Mil.
PT Famon Awal Bros Sedaya Tbk's annual Marketable Securities
declined
from Dec. 2023 (Rp76,000 Mil) to Dec. 2024 (Rp52,000 Mil) but then
increased
from Dec. 2024 (Rp52,000 Mil) to Dec. 2025 (Rp55,000 Mil).
PT Famon Awal Bros Sedaya Tbk (ISX:PRAY) Marketable Securities Explanation
Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.
Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".
PT Famon Awal Bros Sedaya Tbk Marketable Securities Related Terms
PT Famon Awal Bros Sedaya Tbk Marketable Securities Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Famon Awal Bros Sedaya Tbk Marketable Securities Chart
What does a Marketable Securities of Rp45,000 Mil mean?
PT Famon Awal Bros Sedaya Tbk (ISX:PRAY) has a Marketable Securities of Rp45,000 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on PT Famon Awal Bros Sedaya Tbk and its competitors.
Is PT Famon Awal Bros Sedaya Tbk's Marketable Securities too high?
PT Famon Awal Bros Sedaya Tbk's current Marketable Securities is Rp45,000 Mil. Overall, PT Famon Awal Bros Sedaya Tbk has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Famon Awal Bros Sedaya Tbk's Marketable Securities compare to HCA and THC?
PT Famon Awal Bros Sedaya Tbk's Marketable Securities of Rp45,000 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on PT Famon Awal Bros Sedaya Tbk and its competitors. PT Famon Awal Bros Sedaya Tbk's current Marketable Securities is Rp45,000 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Famon Awal Bros Sedaya Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Famon Awal Bros Sedaya Tbk (ISX:PRAY) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp882.97, compared to a current price of Rp750.00 — trading 15.1% below its estimated fair value. The current Marketable Securities is Rp45,000 Mil. PT Famon Awal Bros Sedaya Tbk's overall GF Score™ is 86/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For PT Famon Awal Bros Sedaya Tbk (ISX:PRAY), the current Marketable Securities is Rp45,000 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Famon Awal Bros Sedaya Tbk (ISX:PRAY) Overvalued in 2026?
Based on GuruFocus' analysis, PT Famon Awal Bros Sedaya Tbk stock appears to be undervalued.
The current stock price of Rp750.00 is trading 15.1% below its estimated GF Value™ of Rp882.97.
GuruFocus considers PT Famon Awal Bros Sedaya Tbk to be Modestly Undervalued.
Key valuation signals for ISX:PRAY:
Marketable Securities: Rp45,000 Mil
GF Value™: Rp882.97 vs. price of Rp750.00 (15.1% below fair value)
No single metric tells the full story. See the ISX:PRAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Famon Awal Bros Sedaya Tbk Business Description
PT Famon Awal Bros Sedaya Tbk operates as a hospital. The company7 provides comprehensive health services for Indonesians and foreign nationals (foreigners) and provides patient services with guarantees from companies, insurance, BPJS, and personal payments. Its hospital network has spread across different cities in Indonesia, including Jakarta, Bekasi, Tangerang, Semarang, Sukabumi, Makassar, Palangkaraya, and Pangkal Pinang. The services that it provides for patients include heart and blood vessel service centers, mother and child services, sports clinic & orthopedic services, cancer services, eye care centers & urology centers. The company's segments are Java; Kalimantan dan/ and Sulawesi; and Sumatera. It derives maximum revenue from Jawa.
86GF Score
Get the complete analysis for ISX:PRAY
Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:PRAY has been successfully added to your 
